4//SEC Filing
Began Marc A 4
Accession 0001415889-22-011186
CIK 0000815094other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 4:34 PM ET
Size
15.6 KB
Accession
0001415889-22-011186
Insider Transaction Report
Form 4
ABIOMED INCNASD
Began Marc A
VP & General Counsel
Transactions
- Sale
Common Stock, $0.01 par value
2022-11-04$373.71/sh−2,000$747,420→ 13,785 total - Tax Payment
Common Stock, $0.01 par value
2022-11-05$373.99/sh−1,548$578,937→ 12,237 total
Holdings
- 2,961
Stock Option (Right to Buy)
Exercise: $283.88From: 2022-05-25Exp: 2031-05-25→ Common Stock (0 underlying) - 7,000
Stock Option (Right to Buy)
Exercise: $266.39From: 2020-05-30Exp: 2029-05-30→ Common Stock (0 underlying) - 5,125
Stock Option (Right to Buy)
Exercise: $223.90From: 2021-05-29Exp: 2030-05-29→ Common Stock (0 underlying)
Footnotes (5)
- [F1]Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- [F2]This price represents the sale price of the transactions on the reported date at $373.7100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F3]Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
- [F4]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- [F5]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
Documents
Issuer
ABIOMED INC
CIK 0000815094
Entity typeother
Related Parties
1- filerCIK 0001821352
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 4:34 PM ET
- Size
- 15.6 KB